Redmile Group, LLC Gritstone Bio, Inc. Transaction History

Redmile Group, LLC

$1.53 Billion
Q2 2024

A detailed history of Redmile Group, LLC transactions in Gritstone Bio, Inc. stock. As of the latest transaction made, Redmile Group, LLC holds 5,107,732 shares of GRTS stock, worth $2.4 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

5,107,732

Previous 5,755,075 11.25%

Holding current value

$2.4 Million

Previous $14.8 Million 78.59%

% of portfolio

0.21%

Previous 0.58%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$0.62 - $2.35 $401,352 - $1.52 Million	-647,343 Reduced 11.25%	5,107,732 $3.17 Million
Q1 2024 May 15, 2024	SELL	$1.96 - $2.9 $230,358 - $340,837	-117,530 Reduced 2.0%	5,755,075 $14.8 Million
Q4 2023 Feb 14, 2024	SELL	$1.28 - $2.85 $1.26 Million - $2.81 Million	-987,621 Reduced 14.4%	5,872,605 $12 Million
Q2 2023 Aug 14, 2023	SELL	$1.66 - $3.03 $110,722 - $202,101	-66,700 Reduced 0.96%	6,860,226 $13.4 Million
Q1 2023 May 15, 2023	SELL	$2.13 - $3.74 $9,657 - $16,957	-4,534 Reduced 0.07%	6,926,926 $19.3 Million
Q4 2022 Feb 14, 2023	SELL	$2.17 - $3.92 $46,221 - $83,496	-21,300 Reduced 0.31%	6,931,460 $23.9 Million
Q2 2022 Aug 15, 2022	BUY	$1.77 - $4.34 $143,408 - $351,635	81,022 Added 1.18%	6,952,760 $16.8 Million
Q1 2022 May 16, 2022	BUY	$4.03 - $12.19 $13.9 Million - $42 Million	3,442,567 Added 100.39%	6,871,738 $28.3 Million
Q4 2021 Feb 14, 2022	BUY	$8.76 - $13.71 $5.33 Million - $8.34 Million	608,086 Added 21.56%	3,429,171 $44.1 Million
Q3 2021 Nov 15, 2021	BUY	$6.41 - $13.54 $3.81 Million - $8.05 Million	594,879 Added 26.72%	2,821,085 $30.5 Million
Q2 2021 Aug 16, 2021	SELL	$8.13 - $10.2 $1.8 Million - $2.26 Million	-221,952 Reduced 9.07%	2,226,206 $20.3 Million
Q1 2021 May 17, 2021	SELL	$4.07 - $27.11 $2.49 Million - $16.6 Million	-611,636 Reduced 19.99%	2,448,158 $23.1 Million
Q3 2020 Nov 16, 2020	SELL	$2.63 - $8.09 $13,676 - $42,068	-5,200 Reduced 0.17%	3,059,794 $8.11 Million
Q2 2020 Aug 14, 2020	SELL	$5.69 - $8.17 $18,208 - $26,144	-3,200 Reduced 0.1%	3,064,994 $20.4 Million
Q1 2020 May 15, 2020	SELL	$5.47 - $11.3 $264,748 - $546,920	-48,400 Reduced 1.55%	3,068,194 $17.9 Million
Q4 2019 Feb 14, 2020	BUY	$7.07 - $11.61 $85,547 - $140,481	12,100 Added 0.39%	3,116,594 $28 Million
Q3 2019 Nov 14, 2019	SELL	$8.45 - $12.28 $942,174 - $1.37 Million	-111,500 Reduced 3.47%	3,104,494 $26.8 Million
Q2 2019 Aug 14, 2019	BUY	$9.2 - $15.7 $7.93 Million - $13.5 Million	862,259 Added 36.63%	3,215,994 $35.8 Million
Q1 2019 May 15, 2019	BUY	$9.97 - $18.96 $843,452 - $1.6 Million	84,599 Added 3.73%	2,353,735 $31.3 Million
Q4 2018 Feb 14, 2019	BUY	$11.61 - $31.1 $307,665 - $824,150	26,500 Added 1.18%	2,269,136 $35.1 Million
Q3 2018 Nov 14, 2018	BUY	$14.24 - $14.24 $31.9 Million - $31.9 Million	2,242,636 New	2,242,636 $31.9 Million

Others Institutions Holding GRTS

# of Institutions

Shares Held

37.5M

Call Options Held

1.46M

Put Options Held

168K

View Full List

About Gritstone bio, Inc.

Ticker GRTS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,006,896
Market Cap $34.3M
Description
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...

More about GRTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Redmile Group, LLC with notifications on news.

Account

Redmile Group, LLC Gritstone Bio, Inc. Transaction History